2023
DOI: 10.3389/fgene.2023.1243395
|View full text |Cite
|
Sign up to set email alerts
|

Histone 4 lysine 20 tri-methylation: a key epigenetic regulator in chromatin structure and disease

Alejandra Agredo,
Andrea L. Kasinski

Abstract: Chromatin is a vital and dynamic structure that is carefully regulated to maintain proper cell homeostasis. A great deal of this regulation is dependent on histone proteins which have the ability to be dynamically modified on their tails via various post-translational modifications (PTMs). While multiple histone PTMs are studied and often work in concert to facilitate gene expression, here we focus on the tri-methylation of histone H4 on lysine 20 (H4K20me3) and its function in chromatin structure, cell cycle,… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 105 publications
0
1
0
Order By: Relevance
“…72 Loss of trimethylation of H4K20 is linked to shorter survival and elevated tumor recurrence rates in CRC. 73 To comprehend epigenetic regulation in CRC, patientderived organoids and mouse intestinal organoids were genetically engineered. 74 Results manifest that H4K20 trimethylation deletion mediated by lysine methyltransferase SUV420H2 is discovered to facilitate right-sided colorectal tumorigenesis over chromatin compaction epigenetically controlled, which unravels a promising avenue for CRC subtype-specific therapy.…”
Section: Patient-derived Xenografts and Organoids Modelsmentioning
confidence: 99%
“…72 Loss of trimethylation of H4K20 is linked to shorter survival and elevated tumor recurrence rates in CRC. 73 To comprehend epigenetic regulation in CRC, patientderived organoids and mouse intestinal organoids were genetically engineered. 74 Results manifest that H4K20 trimethylation deletion mediated by lysine methyltransferase SUV420H2 is discovered to facilitate right-sided colorectal tumorigenesis over chromatin compaction epigenetically controlled, which unravels a promising avenue for CRC subtype-specific therapy.…”
Section: Patient-derived Xenografts and Organoids Modelsmentioning
confidence: 99%